# ServiceNow timeline

entity: /record/servicenow.md  
id: ent_servicenow  


## undated

- undated | ticker | NOW | valid | [clm_211DE2CC4B70](/claim/clm_211DE2CC4B70.md)
- undated | state_of_incorporation | DE | valid | [clm_2D1136C1CF8C](/claim/clm_2D1136C1CF8C.md)
- undated | listed_on | NYSE | valid | [clm_366014F32525](/claim/clm_366014F32525.md)
- undated | cik | 0001373715 | valid | [clm_5C05DD17FA35](/claim/clm_5C05DD17FA35.md)
- undated | sic_industry | Services-Prepackaged Software (7372) | valid | [clm_65D3135BF816](/claim/clm_65D3135BF816.md)
- undated to 2006-08-22 | registrant_name | ServiceNow, Inc. | superseded | [clm_6C1FFB3C97F0](/claim/clm_6C1FFB3C97F0.md)
- undated | fiscal_year_end | 12-31 | valid | [clm_7D519602B519](/claim/clm_7D519602B519.md)
- undated | member_of | Business Software Alliance | unverified | [clm_2FE41386297E](/claim/clm_2FE41386297E.md)
- undated | legal_form | Delaware corporation | unverified | [clm_3542041252AA](/claim/clm_3542041252AA.md)
- undated | website | https://www.servicenow.com | unverified | [clm_D7F04A547A79](/claim/clm_D7F04A547A79.md)
- undated | country | United States | valid | [clm_E35813849E32](/claim/clm_E35813849E32.md)

## 2006

- 2006-08-22 to 2012-05-01 | registrant_name | SERVICE-NOW.COM | superseded | [clm_887688AE4C71](/claim/clm_887688AE4C71.md)

## 2008

- 2008-08-07 | x_username | servicenow | unverified | [clm_E087596DF33E](/claim/clm_E087596DF33E.md)

## 2009

- 2009-06-30 to 2010-06-30 | cash_and_equivalents | 7,788,000 United States dollar | superseded | [clm_0107F5643440](/claim/clm_0107F5643440.md)
- 2009-06-30 to 2010-06-30 | total_equity | -21,690,000 United States dollar | superseded | [clm_698F3CFD9AE3](/claim/clm_698F3CFD9AE3.md)

## 2010

- 2010-06-30 to 2011-06-30 | net_income | -29,705,000 United States dollar | superseded | [clm_3F11671F902A](/claim/clm_3F11671F902A.md)
- 2010-06-30 to 2011-06-30 | operating_income | -28,199,000 United States dollar | superseded | [clm_49E370C625AF](/claim/clm_49E370C625AF.md)
- 2010-06-30 to 2011-06-30 | revenue | 43,329,000 United States dollar | superseded | [clm_680C0F2D7A86](/claim/clm_680C0F2D7A86.md)
- 2010-06-30 to 2010-12-31 | cash_and_equivalents | 29,402,000 United States dollar | superseded | [clm_C41AE1D1F76D](/claim/clm_C41AE1D1F76D.md)
- 2010-06-30 to 2011-06-30 | total_equity | -71,262,000 United States dollar | superseded | [clm_C7EA9B7E8C3C](/claim/clm_C7EA9B7E8C3C.md)
- 2010-06-30 to 2011-06-30 | research_and_development | 7,194,000 United States dollar | superseded | [clm_FA42F2DAFBEB](/claim/clm_FA42F2DAFBEB.md)
- 2010-12-31 to 2011-06-30 | cash_and_equivalents | 38,457,000 United States dollar | superseded | [clm_155A0DCA6C7E](/claim/clm_155A0DCA6C7E.md)

## 2011

- 2011-06-30 to 2012-12-31 | operating_income | 10,560,000 United States dollar | superseded | [clm_2DFD620B8331](/claim/clm_2DFD620B8331.md)
- 2011-06-30 to 2012-12-31 | net_income | 9,830,000 United States dollar | superseded | [clm_46041EF9578A](/claim/clm_46041EF9578A.md)
- 2011-06-30 to 2012-12-31 | research_and_development | 7,004,000 United States dollar | superseded | [clm_993F6A998C78](/claim/clm_993F6A998C78.md)
- 2011-06-30 to 2011-12-31 | total_equity | -58,381,000 United States dollar | superseded | [clm_C95331148EDE](/claim/clm_C95331148EDE.md)
- 2011-06-30 to 2012-12-31 | revenue | 92,641,000 United States dollar | superseded | [clm_F9D259FFB8C1](/claim/clm_F9D259FFB8C1.md)
- 2011-06-30 to 2011-09-30 | cash_and_equivalents | 59,853,000 United States dollar | superseded | [clm_FAACE219F830](/claim/clm_FAACE219F830.md)
- 2011-09-30 to 2011-12-31 | cash_and_equivalents | 69,036,000 United States dollar | superseded | [clm_1238E635D5D1](/claim/clm_1238E635D5D1.md)
- 2011-09-30 to 2012-03-31 | quarterly_net_income | 121,000 United States dollar | superseded | [clm_12F0AFCEB5B3](/claim/clm_12F0AFCEB5B3.md)
- 2011-09-30 to 2012-03-31 | quarterly_operating_income | 1,019,000 United States dollar | superseded | [clm_16021F826400](/claim/clm_16021F826400.md)
- 2011-09-30 to 2012-03-31 | quarterly_research_and_development | 2,757,000 United States dollar | superseded | [clm_C58E0A3668B1](/claim/clm_C58E0A3668B1.md)
- 2011-09-30 to 2012-03-31 | quarterly_revenue | 34,197,000 United States dollar | superseded | [clm_D33961895356](/claim/clm_D33961895356.md)
- 2011-12-31 to 2012-03-31 | cash_and_equivalents | 68,088,000 United States dollar | superseded | [clm_1CDDF29C21CC](/claim/clm_1CDDF29C21CC.md)
- 2011-12-31 to 2012-06-30 | total_assets | 156,323,000 United States dollar | superseded | [clm_60A44806ED74](/claim/clm_60A44806ED74.md)
- 2011-12-31 to 2012-06-30 | total_equity | -57,426,000 United States dollar | superseded | [clm_D604358E9C2C](/claim/clm_D604358E9C2C.md)

## 2012

- 2012-03-31 to 2012-06-30 | quarterly_research_and_development | 6,043,000 United States dollar | superseded | [clm_0FBE4EB79A57](/claim/clm_0FBE4EB79A57.md)
- 2012-03-31 to 2012-06-30 | cash_and_equivalents | 80,140,000 United States dollar | superseded | [clm_2883028A8940](/claim/clm_2883028A8940.md)
- 2012-03-31 to 2012-06-30 | quarterly_net_income | -5,640,000 United States dollar | superseded | [clm_66986DF22BD0](/claim/clm_66986DF22BD0.md)
- 2012-03-31 to 2012-06-30 | quarterly_revenue | 47,431,000 United States dollar | superseded | [clm_850299EDF65C](/claim/clm_850299EDF65C.md)
- 2012-03-31 to 2012-06-30 | quarterly_operating_income | -5,582,000 United States dollar | superseded | [clm_D53E6DC84021](/claim/clm_D53E6DC84021.md)
- 2012-06-30 to 2012-09-30 | quarterly_net_income | -8,724,000 United States dollar | superseded | [clm_490AC131F403](/claim/clm_490AC131F403.md)
- 2012-06-30 to 2012-09-30 | total_assets | 200,472,000 United States dollar | superseded | [clm_5AAC3CA1FD0C](/claim/clm_5AAC3CA1FD0C.md)
- 2012-06-30 to 2012-09-30 | quarterly_revenue | 56,774,000 United States dollar | superseded | [clm_A0CF860AE45F](/claim/clm_A0CF860AE45F.md)
- 2012-06-30 to 2012-09-30 | quarterly_research_and_development | 9,272,000 United States dollar | superseded | [clm_B52AE1333E20](/claim/clm_B52AE1333E20.md)
- 2012-06-30 to 2012-09-30 | total_equity | -43,128,000 United States dollar | superseded | [clm_B703221F0380](/claim/clm_B703221F0380.md)
- 2012-06-30 to 2012-09-30 | quarterly_operating_income | -9,117,000 United States dollar | superseded | [clm_F3F3898449D2](/claim/clm_F3F3898449D2.md)
- 2012-06-30 to 2012-09-30 | cash_and_equivalents | 65,482,000 United States dollar | superseded | [clm_FA126F3E9F6F](/claim/clm_FA126F3E9F6F.md)
- 2012-08-06 to 2012-10-25 | shares_outstanding | 123,201,916 shares | superseded | [clm_ED904733BA58](/claim/clm_ED904733BA58.md)
- 2012-09-30 to 2012-12-31 | total_equity | 191,268,000 United States dollar | superseded | [clm_07E5FC569602](/claim/clm_07E5FC569602.md)
- 2012-09-30 to 2012-12-31 | total_assets | 382,204,000 United States dollar | superseded | [clm_155057A12D3F](/claim/clm_155057A12D3F.md)
- 2012-09-30 to 2013-03-31 | quarterly_net_income | -13,053,000 United States dollar | superseded | [clm_2BBE193D4E22](/claim/clm_2BBE193D4E22.md)
- 2012-09-30 to 2013-03-31 | quarterly_revenue | 64,345,000 United States dollar | superseded | [clm_30301F669A82](/claim/clm_30301F669A82.md)
- 2012-09-30 to 2012-12-31 | cash_and_equivalents | 116,976,000 United States dollar | superseded | [clm_B202A9937EE0](/claim/clm_B202A9937EE0.md)
- 2012-09-30 to 2013-03-31 | quarterly_research_and_development | 10,783,000 United States dollar | superseded | [clm_B2E843A149CC](/claim/clm_B2E843A149CC.md)
- 2012-09-30 to 2013-03-31 | quarterly_operating_income | -13,347,000 United States dollar | superseded | [clm_E916D10CD49A](/claim/clm_E916D10CD49A.md)
- 2012-10-25 to 2013-02-28 | shares_outstanding | 123,391,232 shares | superseded | [clm_590F9B776CB6](/claim/clm_590F9B776CB6.md)
- 2012-12-31 to 2013-03-31 | total_assets | 478,114,000 United States dollar | superseded | [clm_1C9D056D1AA7](/claim/clm_1C9D056D1AA7.md)
- 2012-12-31 to 2013-03-31 | total_equity | 243,405,000 United States dollar | superseded | [clm_36FFBD0BBC5D](/claim/clm_36FFBD0BBC5D.md)
- 2012-12-31 to 2013-12-31 | revenue | 243,712,000 United States dollar | superseded | [clm_50ACB7030885](/claim/clm_50ACB7030885.md)
- 2012-12-31 to 2013-12-31 | net_income | -37,348,000 United States dollar | superseded | [clm_532CA1E257EE](/claim/clm_532CA1E257EE.md)
- 2012-12-31 to 2013-12-31 | operating_income | -37,584,000 United States dollar | superseded | [clm_6FF4BB6E1F56](/claim/clm_6FF4BB6E1F56.md)
- 2012-12-31 to 2013-12-31 | research_and_development | 39,333,000 United States dollar | superseded | [clm_82983051557E](/claim/clm_82983051557E.md)
- 2012-12-31 to 2013-03-31 | cash_and_equivalents | 118,989,000 United States dollar | superseded | [clm_E65692B34F3C](/claim/clm_E65692B34F3C.md)

## 2013

- 2013-02-28 to 2013-04-30 | shares_outstanding | 131,900,000 shares | superseded | [clm_01C9E6F65FD5](/claim/clm_01C9E6F65FD5.md)
- 2013-03-31 to 2013-06-30 | quarterly_operating_income | -12,913,000 United States dollar | superseded | [clm_005291222393](/claim/clm_005291222393.md)
- 2013-03-31 to 2013-06-30 | cash_and_equivalents | 144,782,000 United States dollar | superseded | [clm_6ABA638060EF](/claim/clm_6ABA638060EF.md)
- 2013-03-31 to 2013-06-30 | quarterly_net_income | -13,358,000 United States dollar | superseded | [clm_8FBFFD88D3A8](/claim/clm_8FBFFD88D3A8.md)
- 2013-03-31 to 2013-06-30 | quarterly_research_and_development | 16,039,000 United States dollar | superseded | [clm_96DEF906BB2A](/claim/clm_96DEF906BB2A.md)
- 2013-03-31 to 2013-06-30 | total_equity | 263,927,000 United States dollar | superseded | [clm_9CC5ADC7E69E](/claim/clm_9CC5ADC7E69E.md)
- 2013-03-31 to 2013-06-30 | quarterly_revenue | 85,939,000 United States dollar | superseded | [clm_B22CA26B31BB](/claim/clm_B22CA26B31BB.md)
- 2013-03-31 to 2013-06-30 | total_assets | 515,953,000 United States dollar | superseded | [clm_D7BC8B5E2C82](/claim/clm_D7BC8B5E2C82.md)
- 2013-04-30 to 2013-07-31 | shares_outstanding | 134,300,000 shares | superseded | [clm_164394128D83](/claim/clm_164394128D83.md)
- 2013-06-30 to 2013-09-30 | quarterly_operating_income | -19,343,000 United States dollar | superseded | [clm_7DF4E810C3A9](/claim/clm_7DF4E810C3A9.md)
- 2013-06-30 to 2013-09-30 | total_assets | 542,333,000 United States dollar | superseded | [clm_AFFAE601EDAA](/claim/clm_AFFAE601EDAA.md)
- 2013-06-30 to 2013-09-30 | quarterly_net_income | -21,405,000 United States dollar | superseded | [clm_B924DC05905A](/claim/clm_B924DC05905A.md)
- 2013-06-30 to 2013-09-30 | quarterly_research_and_development | 17,951,000 United States dollar | superseded | [clm_BC8D0826B2EF](/claim/clm_BC8D0826B2EF.md)
- 2013-06-30 to 2013-09-30 | cash_and_equivalents | 120,233,000 United States dollar | superseded | [clm_C08E9F94702C](/claim/clm_C08E9F94702C.md)
- 2013-06-30 to 2013-09-30 | quarterly_revenue | 102,222,000 United States dollar | superseded | [clm_D111DF13D0D0](/claim/clm_D111DF13D0D0.md)
- 2013-06-30 to 2013-09-30 | total_equity | 267,895,000 United States dollar | superseded | [clm_D122D839C200](/claim/clm_D122D839C200.md)
- 2013-07-31 to 2013-09-30 | shares_outstanding | 136,800,000 shares | superseded | [clm_4615A987601A](/claim/clm_4615A987601A.md)
- 2013-09-30 to 2014-03-31 | quarterly_net_income | -14,713,000 United States dollar | superseded | [clm_484487486E7E](/claim/clm_484487486E7E.md)
- 2013-09-30 to 2013-12-31 | cash_and_equivalents | 121,094,000 United States dollar | superseded | [clm_54B3358874CB](/claim/clm_54B3358874CB.md)
- 2013-09-30 to 2013-12-31 | total_assets | 578,736,000 United States dollar | superseded | [clm_571C453EA6F9](/claim/clm_571C453EA6F9.md)
- 2013-09-30 to 2013-12-31 | total_equity | 287,596,000 United States dollar | superseded | [clm_59209525A9CA](/claim/clm_59209525A9CA.md)
- 2013-09-30 to 2014-03-31 | quarterly_operating_income | -14,650,000 United States dollar | superseded | [clm_91A4BD71580D](/claim/clm_91A4BD71580D.md)
- 2013-09-30 to 2014-01-31 | shares_outstanding | 138,700,000 shares | superseded | [clm_EAA515DA15C8](/claim/clm_EAA515DA15C8.md)
- 2013-09-30 to 2014-03-31 | quarterly_revenue | 111,259,000 United States dollar | superseded | [clm_FA8B744D6FBA](/claim/clm_FA8B744D6FBA.md)
- 2013-09-30 to 2014-03-31 | quarterly_research_and_development | 20,819,000 United States dollar | superseded | [clm_FB62F0357830](/claim/clm_FB62F0357830.md)
- 2013-12-31 to 2014-12-31 | research_and_development | 78,678,000 United States dollar | superseded | [clm_2170CCAE3186](/claim/clm_2170CCAE3186.md)
- 2013-12-31 to 2014-03-31 | total_assets | 1,168,476,000 United States dollar | superseded | [clm_394A4A9F2FF7](/claim/clm_394A4A9F2FF7.md)
- 2013-12-31 to 2014-12-31 | operating_income | -66,267,000 United States dollar | superseded | [clm_41CC8C8E9F7E](/claim/clm_41CC8C8E9F7E.md)
- 2013-12-31 to 2014-12-31 | net_income | -73,708,000 United States dollar | superseded | [clm_5093DC0C6C79](/claim/clm_5093DC0C6C79.md)
- 2013-12-31 to 2014-12-31 | revenue | 424,650,000 United States dollar | superseded | [clm_7B7E8E855F3F](/claim/clm_7B7E8E855F3F.md)
- 2013-12-31 to 2014-03-31 | total_equity | 394,259,000 United States dollar | superseded | [clm_9272FD6B57B3](/claim/clm_9272FD6B57B3.md)
- 2013-12-31 to 2014-03-31 | cash_and_equivalents | 366,303,000 United States dollar | superseded | [clm_E296A4D0AA89](/claim/clm_E296A4D0AA89.md)

## 2014

- 2014-01-31 to 2014-03-31 | shares_outstanding | 141,100,000 shares | superseded | [clm_BED1E1ECAD43](/claim/clm_BED1E1ECAD43.md)
- 2014-03-31 to 2014-06-30 | total_equity | 403,742,000 United States dollar | superseded | [clm_01D5E5EB3601](/claim/clm_01D5E5EB3601.md)
- 2014-03-31 to 2014-06-30 | quarterly_operating_income | -36,181,000 United States dollar | superseded | [clm_027F5F04905F](/claim/clm_027F5F04905F.md)
- 2014-03-31 to 2014-06-30 | total_assets | 1,224,261,000 United States dollar | superseded | [clm_0E32457DCCF7](/claim/clm_0E32457DCCF7.md)
- 2014-03-31 to 2014-07-31 | shares_outstanding | 143,433,099 shares | superseded | [clm_429FEA4F3C03](/claim/clm_429FEA4F3C03.md)
- 2014-03-31 to 2014-06-30 | quarterly_net_income | -43,311,000 United States dollar | superseded | [clm_4E242DDE98F8](/claim/clm_4E242DDE98F8.md)
- 2014-03-31 to 2014-06-30 | quarterly_revenue | 139,090,000 United States dollar | superseded | [clm_60940A97B78D](/claim/clm_60940A97B78D.md)
- 2014-03-31 to 2014-06-30 | cash_and_equivalents | 337,920,000 United States dollar | superseded | [clm_C0787ACB84E3](/claim/clm_C0787ACB84E3.md)
- 2014-03-31 to 2014-06-30 | quarterly_research_and_development | 31,110,000 United States dollar | superseded | [clm_EBAB4D393160](/claim/clm_EBAB4D393160.md)
- 2014-06-30 to 2014-09-30 | quarterly_net_income | -50,363,000 United States dollar | superseded | [clm_630ED649FCFE](/claim/clm_630ED649FCFE.md)
- 2014-06-30 to 2014-09-30 | quarterly_operating_income | -44,471,000 United States dollar | superseded | [clm_773CDF75BBEE](/claim/clm_773CDF75BBEE.md)
- 2014-06-30 to 2014-09-30 | total_assets | 1,262,243,000 United States dollar | superseded | [clm_B8CB3F997F25](/claim/clm_B8CB3F997F25.md)
- 2014-06-30 to 2014-09-30 | cash_and_equivalents | 329,275,000 United States dollar | superseded | [clm_C11EB6478A0B](/claim/clm_C11EB6478A0B.md)
- 2014-06-30 to 2014-09-30 | quarterly_revenue | 166,757,000 United States dollar | superseded | [clm_D7B5BFBD1970](/claim/clm_D7B5BFBD1970.md)
- 2014-06-30 to 2014-09-30 | quarterly_research_and_development | 35,439,000 United States dollar | superseded | [clm_F099098E4008](/claim/clm_F099098E4008.md)
- 2014-06-30 to 2014-09-30 | total_equity | 398,117,000 United States dollar | superseded | [clm_F567E27B9ED2](/claim/clm_F567E27B9ED2.md)
- 2014-07-31 to 2014-10-31 | shares_outstanding | 145,700,000 shares | superseded | [clm_65A3F7FACDA8](/claim/clm_65A3F7FACDA8.md)
- 2014-09-30 to 2014-12-31 | total_assets | 1,304,612,000 United States dollar | superseded | [clm_36EF988EDA7D](/claim/clm_36EF988EDA7D.md)
- 2014-09-30 to 2015-03-31 | quarterly_net_income | -41,050,000 United States dollar | superseded | [clm_3B7528AC9D0E](/claim/clm_3B7528AC9D0E.md)
- 2014-09-30 to 2015-03-31 | quarterly_revenue | 178,712,000 United States dollar | superseded | [clm_4BF5704D21F6](/claim/clm_4BF5704D21F6.md)
- 2014-09-30 to 2014-12-31 | cash_and_equivalents | 235,086,000 United States dollar | superseded | [clm_90867CA9A097](/claim/clm_90867CA9A097.md)
- 2014-09-30 to 2015-03-31 | quarterly_research_and_development | 39,683,000 United States dollar | superseded | [clm_977130434F6F](/claim/clm_977130434F6F.md)
- 2014-09-30 to 2014-12-31 | total_equity | 417,415,000 United States dollar | superseded | [clm_E354F644B20F](/claim/clm_E354F644B20F.md)
- 2014-09-30 to 2015-03-31 | quarterly_operating_income | -34,499,000 United States dollar | superseded | [clm_F85F70563F4F](/claim/clm_F85F70563F4F.md)
- 2014-10-31 to 2015-01-31 | shares_outstanding | 148,300,000 shares | superseded | [clm_118865DE1132](/claim/clm_118865DE1132.md)
- 2014-12-31 to 2015-03-31 | total_assets | 1,425,079,000 United States dollar | superseded | [clm_0EA67C383B86](/claim/clm_0EA67C383B86.md)
- 2014-12-31 to 2015-12-31 | operating_income | -151,835,000 United States dollar | superseded | [clm_49AC47406EBC](/claim/clm_49AC47406EBC.md)
- 2014-12-31 to 2015-12-31 | revenue | 682,563,000 United States dollar | superseded | [clm_741D84CDFF63](/claim/clm_741D84CDFF63.md)
- 2014-12-31 to 2015-03-31 | cash_and_equivalents | 252,455,000 United States dollar | superseded | [clm_C97500CFBD24](/claim/clm_C97500CFBD24.md)
- 2014-12-31 to 2015-03-31 | total_equity | 428,675,000 United States dollar | superseded | [clm_E36E3BDA1330](/claim/clm_E36E3BDA1330.md)
- 2014-12-31 to 2015-12-31 | research_and_development | 148,258,000 United States dollar | superseded | [clm_E3A76E55B97F](/claim/clm_E3A76E55B97F.md)
- 2014-12-31 to 2015-12-31 | net_income | -179,387,000 United States dollar | superseded | [clm_EA0AEE68E533](/claim/clm_EA0AEE68E533.md)

## 2015

- 2015-01-31 to 2015-04-30 | shares_outstanding | 150,500,000 shares | superseded | [clm_978FA55CC248](/claim/clm_978FA55CC248.md)
- 2015-03-31 to 2015-06-30 | total_equity | 454,910,000 United States dollar | superseded | [clm_2C50FFFCFCE3](/claim/clm_2C50FFFCFCE3.md)
- 2015-03-31 to 2015-06-30 | quarterly_net_income | -58,093,000 United States dollar | superseded | [clm_396B590F51D5](/claim/clm_396B590F51D5.md)
- 2015-03-31 to 2015-06-30 | cash_and_equivalents | 307,981,000 United States dollar | superseded | [clm_91EF576C11B1](/claim/clm_91EF576C11B1.md)
- 2015-03-31 to 2015-06-30 | quarterly_revenue | 211,964,000 United States dollar | superseded | [clm_C85242421449](/claim/clm_C85242421449.md)
- 2015-03-31 to 2015-06-30 | quarterly_operating_income | -54,232,000 United States dollar | superseded | [clm_D5F0C8420F92](/claim/clm_D5F0C8420F92.md)
- 2015-03-31 to 2015-06-30 | quarterly_research_and_development | 49,848,000 United States dollar | superseded | [clm_D66D3B440769](/claim/clm_D66D3B440769.md)
- 2015-03-31 to 2015-06-30 | total_assets | 1,493,642,000 United States dollar | superseded | [clm_F29F0BA2D04D](/claim/clm_F29F0BA2D04D.md)
- 2015-04-30 to 2015-07-31 | shares_outstanding | 153,800,000 shares | superseded | [clm_AB32E2D23C32](/claim/clm_AB32E2D23C32.md)
- 2015-06-30 to 2015-09-30 | total_equity | 463,113,000 United States dollar | superseded | [clm_1F8F279236D3](/claim/clm_1F8F279236D3.md)
- 2015-06-30 to 2015-09-30 | quarterly_research_and_development | 53,276,000 United States dollar | superseded | [clm_21AB91E064CE](/claim/clm_21AB91E064CE.md)
- 2015-06-30 to 2015-09-30 | quarterly_revenue | 246,716,000 United States dollar | superseded | [clm_361D45F89322](/claim/clm_361D45F89322.md)
- 2015-06-30 to 2015-09-30 | total_assets | 1,563,311,000 United States dollar | superseded | [clm_70943ADD6857](/claim/clm_70943ADD6857.md)
- 2015-06-30 to 2015-09-30 | quarterly_net_income | -61,925,000 United States dollar | superseded | [clm_94B1F2781BBA](/claim/clm_94B1F2781BBA.md)
- 2015-06-30 to 2015-09-30 | cash_and_equivalents | 325,354,000 United States dollar | superseded | [clm_D714C9404A56](/claim/clm_D714C9404A56.md)
- 2015-06-30 to 2015-09-30 | quarterly_operating_income | -53,235,000 United States dollar | superseded | [clm_FF77C75270C1](/claim/clm_FF77C75270C1.md)
- 2015-07-31 to 2015-10-31 | shares_outstanding | 156,100,000 shares | superseded | [clm_F2482E0FD3E2](/claim/clm_F2482E0FD3E2.md)
- 2015-09-30 to 2015-12-31 | total_assets | 1,662,888,000 United States dollar | superseded | [clm_23C1B20DF288](/claim/clm_23C1B20DF288.md)
- 2015-09-30 to 2016-03-31 | quarterly_revenue | 261,150,000 United States dollar | superseded | [clm_313DCB67B68F](/claim/clm_313DCB67B68F.md)
- 2015-09-30 to 2015-12-31 | cash_and_equivalents | 349,073,000 United States dollar | superseded | [clm_43A67A6E2903](/claim/clm_43A67A6E2903.md)
- 2015-09-30 to 2015-12-31 | total_equity | 516,934,000 United States dollar | superseded | [clm_5491106DF526](/claim/clm_5491106DF526.md)
- 2015-09-30 to 2016-03-31 | quarterly_net_income | -41,030,000 United States dollar | superseded | [clm_5BC69F2C0BE9](/claim/clm_5BC69F2C0BE9.md)
- 2015-09-30 to 2016-03-31 | quarterly_operating_income | -28,040,000 United States dollar | superseded | [clm_8377B2FD8C63](/claim/clm_8377B2FD8C63.md)
- 2015-09-30 to 2016-03-31 | quarterly_research_and_development | 55,822,000 United States dollar | superseded | [clm_90279245F24D](/claim/clm_90279245F24D.md)
- 2015-10-31 to 2016-01-31 | shares_outstanding | 159,000,000 shares | superseded | [clm_FDE0CAEF833B](/claim/clm_FDE0CAEF833B.md)
- 2015-12-31 to 2016-12-31 | net_income | -198,426,000 United States dollar | superseded | [clm_04DBA7EB94B6](/claim/clm_04DBA7EB94B6.md)
- 2015-12-31 to 2016-03-31 | cash_and_equivalents | 412,305,000 United States dollar | superseded | [clm_16DFACD4E058](/claim/clm_16DFACD4E058.md)
- 2015-12-31 to 2016-03-31 | total_assets | 1,807,052,000 United States dollar | superseded | [clm_35CD518EC4DC](/claim/clm_35CD518EC4DC.md)
- 2015-12-31 to 2016-03-31 | total_equity | 566,814,000 United States dollar | superseded | [clm_7ACB97E22ABE](/claim/clm_7ACB97E22ABE.md)
- 2015-12-31 to 2016-12-31 | research_and_development | 217,389,000 United States dollar | superseded | [clm_8065E83395C5](/claim/clm_8065E83395C5.md)
- 2015-12-31 to 2016-12-31 | revenue | 1,005,480,000 United States dollar | superseded | [clm_E6DF68C9F28D](/claim/clm_E6DF68C9F28D.md)
- 2015-12-31 to 2016-12-31 | operating_income | -166,365,000 United States dollar | superseded | [clm_FD0BC63EDD1C](/claim/clm_FD0BC63EDD1C.md)

## 2016

- 2016-01-31 to 2016-03-31 | shares_outstanding | 161,400,000 shares | superseded | [clm_3B07FFF4F5C1](/claim/clm_3B07FFF4F5C1.md)
- 2016-03-31 to 2016-06-30 | quarterly_revenue | 305,879,000 United States dollar | superseded | [clm_4333435670C6](/claim/clm_4333435670C6.md)
- 2016-03-31 to 2016-06-30 | quarterly_net_income | -333,332,000 United States dollar | superseded | [clm_45BF12E29176](/claim/clm_45BF12E29176.md)
- 2016-03-31 to 2016-06-30 | shares_outstanding | 162,800,000 shares | superseded | [clm_6F35032B350D](/claim/clm_6F35032B350D.md)
- 2016-03-31 to 2016-06-30 | total_equity | 302,356,000 United States dollar | superseded | [clm_760A8FFD93F1](/claim/clm_760A8FFD93F1.md)
- 2016-03-31 to 2016-06-30 | quarterly_research_and_development | 65,924,000 United States dollar | superseded | [clm_9536A6DC8C70](/claim/clm_9536A6DC8C70.md)
- 2016-03-31 to 2016-06-30 | quarterly_operating_income | -324,152,000 United States dollar | superseded | [clm_AB4CCBA5B510](/claim/clm_AB4CCBA5B510.md)
- 2016-03-31 to 2016-06-30 | total_assets | 1,874,043,000 United States dollar | superseded | [clm_AD308CEC3A8A](/claim/clm_AD308CEC3A8A.md)
- 2016-03-31 to 2016-06-30 | cash_and_equivalents | 453,450,000 United States dollar | superseded | [clm_D0859379DD3E](/claim/clm_D0859379DD3E.md)
- 2016-06-30 to 2016-09-30 | cash_and_equivalents | 289,113,000 United States dollar | superseded | [clm_147970085223](/claim/clm_147970085223.md)
- 2016-06-30 to 2016-09-30 | quarterly_operating_income | -48,278,000 United States dollar | superseded | [clm_31701F57316F](/claim/clm_31701F57316F.md)
- 2016-06-30 to 2016-09-30 | total_equity | 324,282,000 United States dollar | superseded | [clm_31A7AB4C0A70](/claim/clm_31A7AB4C0A70.md)
- 2016-06-30 to 2016-09-30 | shares_outstanding | 164,496,689 shares | superseded | [clm_7B14A33E47E4](/claim/clm_7B14A33E47E4.md)
- 2016-06-30 to 2016-09-30 | quarterly_revenue | 341,312,000 United States dollar | superseded | [clm_7B32792D7D3B](/claim/clm_7B32792D7D3B.md)
- 2016-06-30 to 2016-09-30 | total_assets | 1,714,338,000 United States dollar | superseded | [clm_9464956A8423](/claim/clm_9464956A8423.md)
- 2016-06-30 to 2016-09-30 | quarterly_research_and_development | 70,364,000 United States dollar | superseded | [clm_CE1329C41D69](/claim/clm_CE1329C41D69.md)
- 2016-06-30 to 2016-09-30 | quarterly_net_income | -49,625,000 United States dollar | superseded | [clm_E74F792A81BD](/claim/clm_E74F792A81BD.md)
- 2016-09-30 to 2017-03-31 | quarterly_net_income | -36,258,000 United States dollar | superseded | [clm_1F252E838342](/claim/clm_1F252E838342.md)
- 2016-09-30 to 2016-12-31 | total_assets | 1,813,114,000 United States dollar | superseded | [clm_56B8A3B6173F](/claim/clm_56B8A3B6173F.md)
- 2016-09-30 to 2017-03-31 | quarterly_operating_income | -26,775,000 United States dollar | superseded | [clm_6F1D4E79F0DF](/claim/clm_6F1D4E79F0DF.md)
- 2016-09-30 to 2017-01-31 | shares_outstanding | 166,000,000 shares | superseded | [clm_92E2C4E91653](/claim/clm_92E2C4E91653.md)
- 2016-09-30 to 2017-03-31 | quarterly_revenue | 357,656,000 United States dollar | superseded | [clm_B3C111608718](/claim/clm_B3C111608718.md)
- 2016-09-30 to 2016-12-31 | cash_and_equivalents | 325,067,000 United States dollar | superseded | [clm_C0AE3414C9D0](/claim/clm_C0AE3414C9D0.md)
- 2016-09-30 to 2016-12-31 | total_equity | 362,503,000 United States dollar | superseded | [clm_EB1664B6667E](/claim/clm_EB1664B6667E.md)
- 2016-09-30 to 2017-03-31 | quarterly_research_and_development | 75,018,000 United States dollar | superseded | [clm_F47C08EBC476](/claim/clm_F47C08EBC476.md)
- 2016-12-31 to 2017-03-31 | total_equity | 386,961,000 United States dollar | superseded | [clm_2EF9BE425DCD](/claim/clm_2EF9BE425DCD.md)
- 2016-12-31 to 2017-12-31 | research_and_development | 285,239,000 United States dollar | superseded | [clm_4615EB4EA4C3](/claim/clm_4615EB4EA4C3.md)
- 2016-12-31 to 2017-12-31 | operating_income | -422,808,000 United States dollar | superseded | [clm_550B62382B74](/claim/clm_550B62382B74.md)
- 2016-12-31 to 2017-12-31 | revenue | 1,390,513,000 United States dollar | superseded | [clm_83A485C61DCB](/claim/clm_83A485C61DCB.md)
- 2016-12-31 to 2017-03-31 | total_assets | 2,033,767,000 United States dollar | superseded | [clm_A898A1AF096C](/claim/clm_A898A1AF096C.md)
- 2016-12-31 to 2017-12-31 | net_income | -451,804,000 United States dollar | superseded | [clm_B48E538F985F](/claim/clm_B48E538F985F.md)
- 2016-12-31 to 2017-03-31 | cash_and_equivalents | 401,238,000 United States dollar | superseded | [clm_C173D1B0C064](/claim/clm_C173D1B0C064.md)

## 2017

- 2017-01-31 to 2017-03-31 | shares_outstanding | 168,000,000 shares | superseded | [clm_930629FCFB81](/claim/clm_930629FCFB81.md)
- 2017-03-31 to 2017-06-30 | quarterly_net_income | -40,662,000 United States dollar | superseded | [clm_1F959FE18777](/claim/clm_1F959FE18777.md)
- 2017-03-31 to 2017-06-30 | cash_and_equivalents | 439,915,000 United States dollar | superseded | [clm_6676D2D94687](/claim/clm_6676D2D94687.md)
- 2017-03-31 to 2017-06-30 | quarterly_revenue | 416,783,000 United States dollar | superseded | [clm_7561B8B85EB2](/claim/clm_7561B8B85EB2.md)
- 2017-03-31 to 2017-06-30 | total_equity | 427,339,000 United States dollar | superseded | [clm_7B72A6659C11](/claim/clm_7B72A6659C11.md)
- 2017-03-31 to 2017-06-30 | quarterly_research_and_development | 84,489,000 United States dollar | superseded | [clm_80D48B164D8E](/claim/clm_80D48B164D8E.md)
- 2017-03-31 to 2017-06-30 | total_assets | 2,170,263,000 United States dollar | superseded | [clm_8BD4486476CF](/claim/clm_8BD4486476CF.md)
- 2017-03-31 to 2017-06-30 | quarterly_operating_income | -42,490,000 United States dollar | superseded | [clm_9FB90B2DDD41](/claim/clm_9FB90B2DDD41.md)
- 2017-03-31 to 2017-06-30 | shares_outstanding | 169,700,000 shares | superseded | [clm_A5D024428740](/claim/clm_A5D024428740.md)
- 2017-06-30 to 2017-09-30 | shares_outstanding | 170,700,000 shares | superseded | [clm_392A287DB4A1](/claim/clm_392A287DB4A1.md)
- 2017-06-30 to 2017-09-30 | total_assets | 2,924,406,000 United States dollar | superseded | [clm_4EBD4337C8F6](/claim/clm_4EBD4337C8F6.md)
- 2017-06-30 to 2017-09-30 | quarterly_revenue | 471,703,000 United States dollar | superseded | [clm_60F99C0CB619](/claim/clm_60F99C0CB619.md)
- 2017-06-30 to 2017-09-30 | quarterly_research_and_development | 90,005,000 United States dollar | superseded | [clm_976124488DE8](/claim/clm_976124488DE8.md)
- 2017-06-30 to 2017-09-30 | cash_and_equivalents | 1,173,457,000 United States dollar | superseded | [clm_9DA2AD476DD8](/claim/clm_9DA2AD476DD8.md)
- 2017-06-30 to 2017-09-30 | total_equity | 482,426,000 United States dollar | superseded | [clm_9DE925CBF3AC](/claim/clm_9DE925CBF3AC.md)
- 2017-06-30 to 2017-09-30 | quarterly_operating_income | -38,737,000 United States dollar | superseded | [clm_AB9A0D5B3566](/claim/clm_AB9A0D5B3566.md)
- 2017-06-30 to 2017-09-30 | quarterly_net_income | -56,473,000 United States dollar | superseded | [clm_DA65EBEBE93C](/claim/clm_DA65EBEBE93C.md)
- 2017-09-30 to 2018-01-31 | shares_outstanding | 172,700,000 shares | superseded | [clm_148A7E44EA08](/claim/clm_148A7E44EA08.md)
- 2017-09-30 to 2018-03-31 | quarterly_operating_income | -7,055,000 United States dollar | superseded | [clm_55A744F7CC81](/claim/clm_55A744F7CC81.md)
- 2017-09-30 to 2017-12-31 | total_assets | 3,069,515,000 United States dollar | superseded | [clm_6E0C9DBDE139](/claim/clm_6E0C9DBDE139.md)
- 2017-09-30 to 2018-03-31 | quarterly_research_and_development | 98,465,000 United States dollar | superseded | [clm_76746FA7B121](/claim/clm_76746FA7B121.md)
- 2017-09-30 to 2017-12-31 | total_equity | 551,391,000 United States dollar | superseded | [clm_9DF0C5F81976](/claim/clm_9DF0C5F81976.md)
- 2017-09-30 to 2018-03-31 | quarterly_revenue | 498,170,000 United States dollar | superseded | [clm_B2BA275EE8E6](/claim/clm_B2BA275EE8E6.md)
- 2017-09-30 to 2017-12-31 | cash_and_equivalents | 1,104,871,000 United States dollar | superseded | [clm_E3F421E1B17C](/claim/clm_E3F421E1B17C.md)
- 2017-09-30 to 2018-03-31 | quarterly_net_income | -24,188,000 United States dollar | superseded | [clm_F901F9FFC21E](/claim/clm_F901F9FFC21E.md)
- 2017-12-31 to 2018-12-31 | revenue | 1,933,026,000 United States dollar | superseded | [clm_1536666A8D26](/claim/clm_1536666A8D26.md)
- 2017-12-31 to 2018-03-31 | cash_and_equivalents | 726,495,000 United States dollar | superseded | [clm_334365F71D3D](/claim/clm_334365F71D3D.md)
- 2017-12-31 to 2018-03-31 | total_equity | 584,132,000 United States dollar | superseded | [clm_95D0E503762F](/claim/clm_95D0E503762F.md)
- 2017-12-31 to 2018-03-31 | total_assets | 3,397,904,000 United States dollar | superseded | [clm_A2918BF489CC](/claim/clm_A2918BF489CC.md)
- 2017-12-31 to 2018-12-31 | operating_income | -101,414,000 United States dollar | superseded | [clm_D76BA3B16F73](/claim/clm_D76BA3B16F73.md)
- 2017-12-31 to 2018-12-31 | net_income | -149,130,000 United States dollar | superseded | [clm_E3CCF2FFA66A](/claim/clm_E3CCF2FFA66A.md)
- 2017-12-31 to 2018-12-31 | research_and_development | 377,518,000 United States dollar | superseded | [clm_E935CA5DD586](/claim/clm_E935CA5DD586.md)

## 2018

- 2018-01-31 to 2018-03-31 | shares_outstanding | 174,700,000 shares | superseded | [clm_EA786C7E0CFE](/claim/clm_EA786C7E0CFE.md)
- 2018-03-31 to 2018-06-30 | total_assets | 3,704,485,000 United States dollar | superseded | [clm_26131D1ADEC8](/claim/clm_26131D1ADEC8.md)
- 2018-03-31 to 2018-06-30 | shares_outstanding | 176,600,000 shares | superseded | [clm_5E0F266F33E6](/claim/clm_5E0F266F33E6.md)
- 2018-03-31 to 2018-06-30 | quarterly_research_and_development | 117,268,000 United States dollar | superseded | [clm_5E3621B45492](/claim/clm_5E3621B45492.md)
- 2018-03-31 to 2018-06-30 | cash_and_equivalents | 682,854,000 United States dollar | superseded | [clm_79373214B640](/claim/clm_79373214B640.md)
- 2018-03-31 to 2018-06-30 | quarterly_net_income | 10,622,000 United States dollar | superseded | [clm_899FF07B0B8B](/claim/clm_899FF07B0B8B.md)
- 2018-03-31 to 2018-06-30 | quarterly_revenue | 589,222,000 United States dollar | superseded | [clm_9BAE44DB00F9](/claim/clm_9BAE44DB00F9.md)
- 2018-03-31 to 2018-06-30 | total_equity | 865,163,000 United States dollar | superseded | [clm_A98DF9012590](/claim/clm_A98DF9012590.md)
- 2018-03-31 to 2018-06-30 | quarterly_operating_income | -20,283,000 United States dollar | superseded | [clm_FDA98474CFEA](/claim/clm_FDA98474CFEA.md)
- 2018-06-30 to 2018-09-30 | quarterly_operating_income | -31,989,000 United States dollar | superseded | [clm_10428C4B84A8](/claim/clm_10428C4B84A8.md)
- 2018-06-30 to 2018-09-30 | total_assets | 3,472,884,000 United States dollar | superseded | [clm_20F374AD14C6](/claim/clm_20F374AD14C6.md)
- 2018-06-30 to 2018-09-30 | quarterly_revenue | 631,056,000 United States dollar | superseded | [clm_21F4CB5B633F](/claim/clm_21F4CB5B633F.md)
- 2018-06-30 to 2018-09-30 | total_equity | 891,710,000 United States dollar | superseded | [clm_3A1B7EDBBDC3](/claim/clm_3A1B7EDBBDC3.md)
- 2018-06-30 to 2018-09-30 | quarterly_net_income | -52,746,000 United States dollar | superseded | [clm_6A4639677F4B](/claim/clm_6A4639677F4B.md)
- 2018-06-30 to 2018-09-30 | cash_and_equivalents | 704,846,000 United States dollar | superseded | [clm_88D867BF808F](/claim/clm_88D867BF808F.md)
- 2018-06-30 to 2018-09-30 | quarterly_research_and_development | 127,916,000 United States dollar | superseded | [clm_994DBC836297](/claim/clm_994DBC836297.md)
- 2018-06-30 to 2018-09-30 | shares_outstanding | 177,900,000 shares | superseded | [clm_EE23DA8334CE](/claim/clm_EE23DA8334CE.md)
- 2018-09-30 to 2018-12-31 | total_equity | 1,020,184,000 United States dollar | superseded | [clm_00DD434BB3FC](/claim/clm_00DD434BB3FC.md)
- 2018-09-30 to 2018-12-31 | total_assets | 3,581,442,000 United States dollar | superseded | [clm_30A7DA5BAAAB](/claim/clm_30A7DA5BAAAB.md)
- 2018-09-30 to 2019-03-31 | quarterly_revenue | 673,097,000 United States dollar | superseded | [clm_5C72004D2F1F](/claim/clm_5C72004D2F1F.md)
- 2018-09-30 to 2019-01-31 | shares_outstanding | 179,300,000 shares | superseded | [clm_90D2365A3A4F](/claim/clm_90D2365A3A4F.md)
- 2018-09-30 to 2018-12-31 | cash_and_equivalents | 703,629,000 United States dollar | superseded | [clm_999B8C9C8854](/claim/clm_999B8C9C8854.md)
- 2018-09-30 to 2019-03-31 | quarterly_operating_income | 9,568,000 United States dollar | superseded | [clm_C8242E9930CA](/claim/clm_C8242E9930CA.md)
- 2018-09-30 to 2019-03-31 | quarterly_research_and_development | 135,655,000 United States dollar | superseded | [clm_E0DE89F1AEF5](/claim/clm_E0DE89F1AEF5.md)
- 2018-09-30 to 2019-03-31 | quarterly_net_income | 8,405,000 United States dollar | superseded | [clm_EBE5E36F76AA](/claim/clm_EBE5E36F76AA.md)
- 2018-12-31 to 2019-03-31 | total_assets | 3,879,140,000 United States dollar | superseded | [clm_2EE2DD0CEC7D](/claim/clm_2EE2DD0CEC7D.md)
- 2018-12-31 to 2019-03-31 | cash_and_equivalents | 566,204,000 United States dollar | superseded | [clm_57DD56EC3C97](/claim/clm_57DD56EC3C97.md)
- 2018-12-31 to 2019-12-31 | revenue | 2,608,816,000 United States dollar | superseded | [clm_74D2912DE7D0](/claim/clm_74D2912DE7D0.md)
- 2018-12-31 to 2019-12-31 | operating_income | -42,426,000 United States dollar | superseded | [clm_778E1DAA5518](/claim/clm_778E1DAA5518.md)
- 2018-12-31 to 2019-12-31 | net_income | -26,704,000 United States dollar | superseded | [clm_B4213EFFBBAB](/claim/clm_B4213EFFBBAB.md)
- 2018-12-31 to 2019-03-31 | total_equity | 1,111,199,000 United States dollar | superseded | [clm_C35E778397B5](/claim/clm_C35E778397B5.md)
- 2018-12-31 to 2019-12-31 | research_and_development | 529,501,000 United States dollar | superseded | [clm_F4080CB1D76E](/claim/clm_F4080CB1D76E.md)

## 2019

- 2019-01-31 to 2019-03-31 | shares_outstanding | 180,500,000 shares | superseded | [clm_50DCA8FD8D59](/claim/clm_50DCA8FD8D59.md)
- 2019-03-31 to 2019-06-30 | quarterly_revenue | 788,926,000 United States dollar | superseded | [clm_58C95959FCC7](/claim/clm_58C95959FCC7.md)
- 2019-03-31 to 2019-06-30 | total_assets | 4,398,895,000 United States dollar | superseded | [clm_5D06B21B5F4E](/claim/clm_5D06B21B5F4E.md)
- 2019-03-31 to 2019-06-30 | quarterly_operating_income | -15,713,000 United States dollar | superseded | [clm_7ADAAD1381CC](/claim/clm_7ADAAD1381CC.md)
- 2019-03-31 to 2019-06-30 | total_equity | 1,194,951,000 United States dollar | superseded | [clm_9FC5C6ACEDC5](/claim/clm_9FC5C6ACEDC5.md)
- 2019-03-31 to 2019-06-30 | shares_outstanding | 184,700,000 shares | superseded | [clm_B52A52C772AD](/claim/clm_B52A52C772AD.md)
- 2019-03-31 to 2019-06-30 | quarterly_research_and_development | 172,522,000 United States dollar | superseded | [clm_C45F3048658C](/claim/clm_C45F3048658C.md)
- 2019-03-31 to 2019-06-30 | cash_and_equivalents | 639,722,000 United States dollar | superseded | [clm_F6320DB7249D](/claim/clm_F6320DB7249D.md)
- 2019-03-31 to 2019-06-30 | quarterly_net_income | -1,545,000 United States dollar | superseded | [clm_F6C05ADF4BD6](/claim/clm_F6C05ADF4BD6.md)
- 2019-06-30 to 2019-09-30 | total_equity | 1,260,946,000 United States dollar | superseded | [clm_29358E121CF5](/claim/clm_29358E121CF5.md)
- 2019-06-30 to 2019-09-30 | quarterly_revenue | 833,904,000 United States dollar | superseded | [clm_564D3C569CDF](/claim/clm_564D3C569CDF.md)
- 2019-06-30 to 2019-09-30 | total_assets | 4,602,703,000 United States dollar | superseded | [clm_94415A31310A](/claim/clm_94415A31310A.md)
- 2019-06-30 to 2019-09-30 | quarterly_net_income | -11,079,000 United States dollar | superseded | [clm_981ACBCB67B7](/claim/clm_981ACBCB67B7.md)
- 2019-06-30 to 2019-09-30 | cash_and_equivalents | 583,581,000 United States dollar | superseded | [clm_9C86BC5C3881](/claim/clm_9C86BC5C3881.md)
- 2019-06-30 to 2019-09-30 | quarterly_operating_income | -27,000,000 United States dollar | superseded | [clm_E67E3DDB5897](/claim/clm_E67E3DDB5897.md)
- 2019-06-30 to 2019-09-30 | shares_outstanding | 187,500,000 shares | superseded | [clm_F10E23C88AA2](/claim/clm_F10E23C88AA2.md)
- 2019-06-30 to 2019-09-30 | quarterly_research_and_development | 183,420,000 United States dollar | superseded | [clm_FD9D872184E8](/claim/clm_FD9D872184E8.md)
- 2019-09-30 to 2020-01-31 | shares_outstanding | 188,600,000 shares | superseded | [clm_0AA55371E70F](/claim/clm_0AA55371E70F.md)
- 2019-09-30 to 2019-12-31 | cash_and_equivalents | 622,925,000 United States dollar | superseded | [clm_0D8E9ABAB551](/claim/clm_0D8E9ABAB551.md)
- 2019-09-30 to 2019-12-31 | total_assets | 4,756,808,000 United States dollar | superseded | [clm_423A3F418FC7](/claim/clm_423A3F418FC7.md)
- 2019-09-30 to 2020-03-31 | quarterly_revenue | 885,833,000 United States dollar | superseded | [clm_80DFC8C69AAF](/claim/clm_80DFC8C69AAF.md)
- 2019-09-30 to 2020-03-31 | quarterly_net_income | 40,598,000 United States dollar | superseded | [clm_861C1A6C31FA](/claim/clm_861C1A6C31FA.md)
- 2019-09-30 to 2020-03-31 | quarterly_research_and_development | 190,099,000 United States dollar | superseded | [clm_9C2909D38146](/claim/clm_9C2909D38146.md)
- 2019-09-30 to 2019-12-31 | total_equity | 1,429,473,000 United States dollar | superseded | [clm_C6AD5A3FD97D](/claim/clm_C6AD5A3FD97D.md)
- 2019-09-30 to 2020-03-31 | quarterly_operating_income | 56,324,000 United States dollar | superseded | [clm_C75F66A1A616](/claim/clm_C75F66A1A616.md)
- 2019-12-31 to 2020-12-31 | revenue | 3,460,437,000 United States dollar | superseded | [clm_11D645752F01](/claim/clm_11D645752F01.md)
- 2019-12-31 to 2020-12-31 | net_income | 626,698,000 United States dollar | superseded | [clm_14F2489725FB](/claim/clm_14F2489725FB.md)
- 2019-12-31 to 2020-12-31 | operating_income | 42,123,000 United States dollar | superseded | [clm_26F1D0B38257](/claim/clm_26F1D0B38257.md)
- 2019-12-31 to 2025-12-31 | employees | 10,371 | superseded | [clm_383340A70372](/claim/clm_383340A70372.md)
- 2019-12-31 to 2020-12-31 | research_and_development | 748,369,000 United States dollar | superseded | [clm_8A4521B8C429](/claim/clm_8A4521B8C429.md)
- 2019-12-31 to 2020-03-31 | total_equity | 2,127,941,000 United States dollar | superseded | [clm_B0A90CDC8937](/claim/clm_B0A90CDC8937.md)
- 2019-12-31 to 2020-03-31 | total_assets | 6,022,430,000 United States dollar | superseded | [clm_E1131DED1204](/claim/clm_E1131DED1204.md)
- 2019-12-31 to 2020-03-31 | cash_and_equivalents | 775,778,000 United States dollar | superseded | [clm_E775F17E2784](/claim/clm_E775F17E2784.md)

## 2020

- 2020-01-31 to 2020-03-31 | shares_outstanding | 189,800,000 shares | superseded | [clm_87078A51105D](/claim/clm_87078A51105D.md)
- 2020-03-31 to 2020-06-30 | quarterly_revenue | 1,046,340,000 United States dollar | superseded | [clm_137E7C770488](/claim/clm_137E7C770488.md)
- 2020-03-31 to 2020-06-30 | total_equity | 2,266,095,000 United States dollar | superseded | [clm_27E3204FD519](/claim/clm_27E3204FD519.md)
- 2020-03-31 to 2020-06-30 | quarterly_operating_income | 49,335,000 United States dollar | superseded | [clm_3711369A3513](/claim/clm_3711369A3513.md)
- 2020-03-31 to 2020-06-30 | shares_outstanding | 190,700,000 shares | superseded | [clm_3ED695B8E345](/claim/clm_3ED695B8E345.md)
- 2020-03-31 to 2020-06-30 | quarterly_research_and_development | 226,657,000 United States dollar | superseded | [clm_D1D7CE96F48C](/claim/clm_D1D7CE96F48C.md)
- 2020-03-31 to 2020-06-30 | quarterly_net_income | 48,231,000 United States dollar | superseded | [clm_EB14A0199629](/claim/clm_EB14A0199629.md)
- 2020-03-31 to 2020-06-30 | total_assets | 6,197,416,000 United States dollar | superseded | [clm_F45547CA83C8](/claim/clm_F45547CA83C8.md)
- 2020-03-31 to 2020-06-30 | cash_and_equivalents | 808,725,000 United States dollar | superseded | [clm_FD5D3C374345](/claim/clm_FD5D3C374345.md)
- 2020-06-30 to 2020-09-30 | cash_and_equivalents | 837,309,000 United States dollar | superseded | [clm_013500976B68](/claim/clm_013500976B68.md)
- 2020-06-30 to 2020-09-30 | quarterly_revenue | 1,070,842,000 United States dollar | superseded | [clm_2F8C3580B815](/claim/clm_2F8C3580B815.md)
- 2020-06-30 to 2020-09-30 | total_assets | 6,521,309,000 United States dollar | superseded | [clm_3B58E846DBD2](/claim/clm_3B58E846DBD2.md)
- 2020-06-30 to 2020-09-30 | shares_outstanding | 191,800,000 shares | superseded | [clm_82343CF0860B](/claim/clm_82343CF0860B.md)
- 2020-06-30 to 2020-09-30 | quarterly_research_and_development | 245,081,000 United States dollar | superseded | [clm_9B81ED2F6A56](/claim/clm_9B81ED2F6A56.md)
- 2020-06-30 to 2020-09-30 | quarterly_operating_income | 62,266,000 United States dollar | superseded | [clm_A857850FD465](/claim/clm_A857850FD465.md)
- 2020-06-30 to 2020-09-30 | quarterly_net_income | 40,766,000 United States dollar | superseded | [clm_B5DBC6423C68](/claim/clm_B5DBC6423C68.md)
- 2020-06-30 to 2020-09-30 | total_equity | 2,478,806,000 United States dollar | superseded | [clm_EAE6123C9ED0](/claim/clm_EAE6123C9ED0.md)
- 2020-09-30 to 2020-12-31 | total_equity | 2,673,716,000 United States dollar | superseded | [clm_0A9ABF11C58F](/claim/clm_0A9ABF11C58F.md)
- 2020-09-30 to 2021-03-31 | quarterly_revenue | 1,151,972,000 United States dollar | superseded | [clm_13EF704BE915](/claim/clm_13EF704BE915.md)
- 2020-09-30 to 2020-12-31 | total_assets | 7,705,459,000 United States dollar | superseded | [clm_72844C181BF6](/claim/clm_72844C181BF6.md)
- 2020-09-30 to 2021-03-31 | quarterly_net_income | 12,858,000 United States dollar | superseded | [clm_833C8C8E32E8](/claim/clm_833C8C8E32E8.md)
- 2020-09-30 to 2021-01-31 | shares_outstanding | 195,100,000 shares | superseded | [clm_8AD4932786E5](/claim/clm_8AD4932786E5.md)
- 2020-09-30 to 2021-03-31 | quarterly_research_and_development | 268,292,000 United States dollar | superseded | [clm_9D17BA354CC5](/claim/clm_9D17BA354CC5.md)
- 2020-09-30 to 2020-12-31 | cash_and_equivalents | 1,348,294,000 United States dollar | superseded | [clm_DE104D67C208](/claim/clm_DE104D67C208.md)
- 2020-09-30 to 2021-03-31 | quarterly_operating_income | 69,332,000 United States dollar | superseded | [clm_E47DA028AA4D](/claim/clm_E47DA028AA4D.md)
- 2020-12-31 to 2021-03-31 | total_assets | 8,715,057,000 United States dollar | superseded | [clm_42ACD3547D56](/claim/clm_42ACD3547D56.md)
- 2020-12-31 to 2021-12-31 | net_income | 118,503,000 United States dollar | superseded | [clm_4684AD93AC12](/claim/clm_4684AD93AC12.md)
- 2020-12-31 to 2021-12-31 | revenue | 4,519,484,000 United States dollar | superseded | [clm_48C75BDC1C61](/claim/clm_48C75BDC1C61.md)
- 2020-12-31 to 2021-03-31 | total_equity | 2,834,481,000 United States dollar | superseded | [clm_79152B762A93](/claim/clm_79152B762A93.md)
- 2020-12-31 to 2021-12-31 | operating_income | 198,863,000 United States dollar | superseded | [clm_8A630FC59A2A](/claim/clm_8A630FC59A2A.md)
- 2020-12-31 to 2021-12-31 | research_and_development | 1,024,327,000 United States dollar | superseded | [clm_EADC4D2E769B](/claim/clm_EADC4D2E769B.md)
- 2020-12-31 to 2021-03-31 | cash_and_equivalents | 1,676,794,000 United States dollar | superseded | [clm_FADCBD1AD416](/claim/clm_FADCBD1AD416.md)

## 2021

- 2021-01-31 to 2021-03-31 | shares_outstanding | 196,100,000 shares | superseded | [clm_958614DA619F](/claim/clm_958614DA619F.md)
- 2021-03-31 to 2021-06-30 | shares_outstanding | 197,400,000 shares | superseded | [clm_01F3E2C50A1A](/claim/clm_01F3E2C50A1A.md)
- 2021-03-31 to 2021-06-30 | total_assets | 8,822,000,000 United States dollar | superseded | [clm_033B92D5A977](/claim/clm_033B92D5A977.md)
- 2021-03-31 to 2021-06-30 | quarterly_revenue | 1,360,000,000 United States dollar | superseded | [clm_11F134F71038](/claim/clm_11F134F71038.md)
- 2021-03-31 to 2021-06-30 | quarterly_research_and_development | 314,000,000 United States dollar | superseded | [clm_23365C58CA41](/claim/clm_23365C58CA41.md)
- 2021-03-31 to 2021-06-30 | cash_and_equivalents | 1,821,000,000 United States dollar | superseded | [clm_2BD739E6DD6D](/claim/clm_2BD739E6DD6D.md)
- 2021-03-31 to 2021-06-30 | quarterly_net_income | 82,440,000 United States dollar | superseded | [clm_809778C3CC1E](/claim/clm_809778C3CC1E.md)
- 2021-03-31 to 2021-06-30 | total_equity | 3,037,000,000 United States dollar | superseded | [clm_CDE0A17069A8](/claim/clm_CDE0A17069A8.md)
- 2021-03-31 to 2021-06-30 | quarterly_operating_income | 97,000,000 United States dollar | superseded | [clm_F16ECB0B9349](/claim/clm_F16ECB0B9349.md)
- 2021-06-30 to 2021-09-30 | quarterly_net_income | 59,000,000 United States dollar | superseded | [clm_097B0BE810E4](/claim/clm_097B0BE810E4.md)
- 2021-06-30 to 2021-09-30 | cash_and_equivalents | 1,362,000,000 United States dollar | superseded | [clm_58515E19A40B](/claim/clm_58515E19A40B.md)
- 2021-06-30 to 2021-09-30 | total_equity | 3,275,000,000 United States dollar | superseded | [clm_60F4D4B60ED1](/claim/clm_60F4D4B60ED1.md)
- 2021-06-30 to 2021-09-30 | shares_outstanding | 198,100,000 shares | superseded | [clm_92BCBB906158](/claim/clm_92BCBB906158.md)
- 2021-06-30 to 2021-09-30 | total_assets | 9,187,000,000 United States dollar | superseded | [clm_ACBC6107AC3E](/claim/clm_ACBC6107AC3E.md)
- 2021-06-30 to 2021-09-30 | quarterly_operating_income | 51,000,000 United States dollar | superseded | [clm_BC54E83634A1](/claim/clm_BC54E83634A1.md)
- 2021-06-30 to 2021-09-30 | quarterly_revenue | 1,409,000,000 United States dollar | superseded | [clm_DA3AA5D5A1EC](/claim/clm_DA3AA5D5A1EC.md)
- 2021-06-30 to 2021-09-30 | quarterly_research_and_development | 333,000,000 United States dollar | superseded | [clm_F084F2BF49A3](/claim/clm_F084F2BF49A3.md)
- 2021-09-30 to 2021-12-31 | total_assets | 9,478,000,000 United States dollar | superseded | [clm_024AAD2B236E](/claim/clm_024AAD2B236E.md)
- 2021-09-30 to 2021-12-31 | total_equity | 3,534,000,000 United States dollar | superseded | [clm_2EE9C8FF1EA0](/claim/clm_2EE9C8FF1EA0.md)
- 2021-09-30 to 2022-03-31 | quarterly_net_income | 62,890,000 United States dollar | superseded | [clm_4D4159B94CD6](/claim/clm_4D4159B94CD6.md)
- 2021-09-30 to 2022-03-31 | quarterly_research_and_development | 358,000,000 United States dollar | superseded | [clm_5F406432D8A5](/claim/clm_5F406432D8A5.md)
- 2021-09-30 to 2022-03-31 | quarterly_revenue | 1,512,000,000 United States dollar | superseded | [clm_7393A10C76EA](/claim/clm_7393A10C76EA.md)
- 2021-09-30 to 2022-01-31 | shares_outstanding | 199,000,000 shares | superseded | [clm_7EA1ED0FD506](/claim/clm_7EA1ED0FD506.md)
- 2021-09-30 to 2021-12-31 | cash_and_equivalents | 1,400,000,000 United States dollar | superseded | [clm_8A6772564564](/claim/clm_8A6772564564.md)
- 2021-09-30 to 2022-03-31 | quarterly_operating_income | 74,000,000 United States dollar | superseded | [clm_D8D0F5C6701A](/claim/clm_D8D0F5C6701A.md)
- 2021-12-31 to 2022-03-31 | total_equity | 3,695,000,000 United States dollar | superseded | [clm_0E124D41D283](/claim/clm_0E124D41D283.md)
- 2021-12-31 to 2022-12-31 | revenue | 5,896,000,000 United States dollar | superseded | [clm_25009DCE545D](/claim/clm_25009DCE545D.md)
- 2021-12-31 to 2022-03-31 | total_assets | 10,798,000,000 United States dollar | superseded | [clm_31914931A7CD](/claim/clm_31914931A7CD.md)
- 2021-12-31 to 2022-12-31 | net_income | 230,141,000 United States dollar | superseded | [clm_4899FD9C49C6](/claim/clm_4899FD9C49C6.md)
- 2021-12-31 to 2022-03-31 | cash_and_equivalents | 1,728,000,000 United States dollar | superseded | [clm_59A7278E62B5](/claim/clm_59A7278E62B5.md)
- 2021-12-31 to 2022-12-31 | research_and_development | 1,397,000,000 United States dollar | superseded | [clm_A3E677046BCF](/claim/clm_A3E677046BCF.md)
- 2021-12-31 to 2022-12-31 | operating_income | 257,000,000 United States dollar | superseded | [clm_BF067EC1FF97](/claim/clm_BF067EC1FF97.md)

## 2022

- 2022-01-31 to 2022-03-31 | shares_outstanding | 200,000,000 shares | superseded | [clm_C0F036F92ED2](/claim/clm_C0F036F92ED2.md)
- 2022-03-31 to 2022-06-30 | total_assets | 10,993,000,000 United States dollar | superseded | [clm_346371021FFC](/claim/clm_346371021FFC.md)
- 2022-03-31 to 2022-06-30 | quarterly_net_income | 75,350,000 United States dollar | superseded | [clm_4AE5A3069D13](/claim/clm_4AE5A3069D13.md)
- 2022-03-31 to 2022-06-30 | quarterly_operating_income | 87,000,000 United States dollar | superseded | [clm_508F5B65F5AA](/claim/clm_508F5B65F5AA.md)
- 2022-03-31 to 2022-06-30 | quarterly_research_and_development | 414,000,000 United States dollar | superseded | [clm_8EB4EB0A7A9C](/claim/clm_8EB4EB0A7A9C.md)
- 2022-03-31 to 2022-06-30 | quarterly_revenue | 1,722,000,000 United States dollar | superseded | [clm_9A6DA5E47D51](/claim/clm_9A6DA5E47D51.md)
- 2022-03-31 to 2022-06-30 | cash_and_equivalents | 2,252,000,000 United States dollar | superseded | [clm_A68EA1EB803A](/claim/clm_A68EA1EB803A.md)
- 2022-03-31 to 2022-06-30 | shares_outstanding | 200,000,000 shares | superseded | [clm_BA66AD11F474](/claim/clm_BA66AD11F474.md)
- 2022-03-31 to 2022-06-30 | total_equity | 3,997,000,000 United States dollar | superseded | [clm_E5BD301A267C](/claim/clm_E5BD301A267C.md)
- 2022-06-30 to 2022-09-30 | total_equity | 4,194,000,000 United States dollar | superseded | [clm_1016157ADE95](/claim/clm_1016157ADE95.md)
- 2022-06-30 to 2022-09-30 | quarterly_net_income | 19,772,000 United States dollar | superseded | [clm_28E97A826617](/claim/clm_28E97A826617.md)
- 2022-06-30 to 2022-09-30 | quarterly_research_and_development | 444,000,000 United States dollar | superseded | [clm_3BD09DC72CF3](/claim/clm_3BD09DC72CF3.md)
- 2022-06-30 to 2022-09-30 | total_assets | 11,102,000,000 United States dollar | superseded | [clm_6585005F16FA](/claim/clm_6585005F16FA.md)
- 2022-06-30 to 2022-09-30 | shares_outstanding | 201,600,000 shares | superseded | [clm_6F9C61F71021](/claim/clm_6F9C61F71021.md)
- 2022-06-30 to 2022-09-30 | cash_and_equivalents | 1,664,000,000 United States dollar | superseded | [clm_907EF2567D27](/claim/clm_907EF2567D27.md)
- 2022-06-30 to 2022-09-30 | quarterly_revenue | 1,752,000,000 United States dollar | superseded | [clm_B32F4C1B8078](/claim/clm_B32F4C1B8078.md)
- 2022-06-30 to 2022-09-30 | quarterly_operating_income | 22,000,000 United States dollar | superseded | [clm_F96873AA4C65](/claim/clm_F96873AA4C65.md)
- 2022-09-30 to 2022-12-31 | total_equity | 4,523,000,000 United States dollar | superseded | [clm_06E76200F005](/claim/clm_06E76200F005.md)
- 2022-09-30 to 2022-12-31 | total_assets | 11,106,000,000 United States dollar | superseded | [clm_66F97B164D9D](/claim/clm_66F97B164D9D.md)
- 2022-09-30 to 2023-01-25 | shares_outstanding | 202,400,000 shares | superseded | [clm_74AC8E960A76](/claim/clm_74AC8E960A76.md)
- 2022-09-30 to 2023-03-31 | quarterly_net_income | 79,749,000 United States dollar | superseded | [clm_A4922BF5E00B](/claim/clm_A4922BF5E00B.md)
- 2022-09-30 to 2023-03-31 | quarterly_revenue | 1,831,000,000 United States dollar | superseded | [clm_ACB24239C419](/claim/clm_ACB24239C419.md)
- 2022-09-30 to 2022-12-31 | cash_and_equivalents | 1,248,000,000 United States dollar | superseded | [clm_C47C0067B3D2](/claim/clm_C47C0067B3D2.md)
- 2022-09-30 to 2023-03-31 | quarterly_operating_income | 91,000,000 United States dollar | superseded | [clm_E4D83DA4AB4D](/claim/clm_E4D83DA4AB4D.md)
- 2022-09-30 to 2023-03-31 | quarterly_research_and_development | 456,000,000 United States dollar | superseded | [clm_E654EBCC1C7C](/claim/clm_E654EBCC1C7C.md)
- 2022-12-31 to 2023-12-31 | research_and_development | 1,768,000,000 United States dollar | superseded | [clm_00AB8CC7BFC3](/claim/clm_00AB8CC7BFC3.md)
- 2022-12-31 to 2023-12-31 | net_income | 325,000,000 United States dollar | superseded | [clm_0C9EAB5C0F82](/claim/clm_0C9EAB5C0F82.md)
- 2022-12-31 to 2023-03-31 | total_assets | 13,299,000,000 United States dollar | superseded | [clm_2E0203D5053A](/claim/clm_2E0203D5053A.md)
- 2022-12-31 to 2023-12-31 | operating_income | 355,000,000 United States dollar | superseded | [clm_44BF159CC23B](/claim/clm_44BF159CC23B.md)
- 2022-12-31 to 2023-03-31 | total_equity | 5,032,000,000 United States dollar | superseded | [clm_5A9C35FB16A6](/claim/clm_5A9C35FB16A6.md)
- 2022-12-31 to 2023-03-31 | cash_and_equivalents | 1,470,000,000 United States dollar | superseded | [clm_6268EEB87665](/claim/clm_6268EEB87665.md)
- 2022-12-31 to 2023-12-31 | revenue | 7,245,000,000 United States dollar | superseded | [clm_C77A55A87C81](/claim/clm_C77A55A87C81.md)

## 2023

- 2023-01-24 | coo | Chirantan Desai | valid | [clm_7F1E37F09D10](/claim/clm_7F1E37F09D10.md)
- 2023-01-24 | president | Chirantan Desai | valid | [clm_FD79CFB7287F](/claim/clm_FD79CFB7287F.md)
- 2023-01-25 to 2023-03-31 | shares_outstanding | 203,000,000 shares | superseded | [clm_CCC576AA6A5B](/claim/clm_CCC576AA6A5B.md)
- 2023-03-31 to 2023-06-30 | quarterly_net_income | 150,000,000 United States dollar | superseded | [clm_12C93AA83E40](/claim/clm_12C93AA83E40.md)
- 2023-03-31 to 2023-06-30 | total_assets | 13,614,000,000 United States dollar | superseded | [clm_2435B735F89B](/claim/clm_2435B735F89B.md)
- 2023-03-31 to 2023-06-30 | quarterly_research_and_development | 492,000,000 United States dollar | superseded | [clm_263516FA4B95](/claim/clm_263516FA4B95.md)
- 2023-03-31 to 2023-06-30 | quarterly_operating_income | 144,000,000 United States dollar | superseded | [clm_27AFA2A19425](/claim/clm_27AFA2A19425.md)
- 2023-03-31 to 2023-06-30 | cash_and_equivalents | 1,852,000,000 United States dollar | superseded | [clm_2E1993C557A0](/claim/clm_2E1993C557A0.md)
- 2023-03-31 to 2023-06-30 | total_equity | 5,600,000,000 United States dollar | superseded | [clm_494B8E264580](/claim/clm_494B8E264580.md)
- 2023-03-31 to 2023-06-30 | shares_outstanding | 203,700,000 shares | superseded | [clm_7C74D18EB548](/claim/clm_7C74D18EB548.md)
- 2023-03-31 to 2023-06-30 | quarterly_revenue | 2,096,000,000 United States dollar | superseded | [clm_AFE763BA9DCC](/claim/clm_AFE763BA9DCC.md)
- 2023-04-25 | board_member | Deborah Black | valid | [clm_7334118F1576](/claim/clm_7334118F1576.md)
- 2023-06-30 to 2023-09-30 | total_assets | 14,923,000,000 United States dollar | superseded | [clm_10BCE5F1E16D](/claim/clm_10BCE5F1E16D.md)
- 2023-06-30 to 2023-09-30 | quarterly_research_and_development | 521,000,000 United States dollar | superseded | [clm_199411DE1650](/claim/clm_199411DE1650.md)
- 2023-06-30 to 2023-09-30 | total_equity | 6,926,000,000 United States dollar | superseded | [clm_423322022317](/claim/clm_423322022317.md)
- 2023-06-30 to 2023-09-30 | quarterly_net_income | 1,044,000,000 United States dollar | superseded | [clm_614A6D311221](/claim/clm_614A6D311221.md)
- 2023-06-30 to 2023-09-30 | quarterly_revenue | 2,150,000,000 United States dollar | superseded | [clm_65950133B3B7](/claim/clm_65950133B3B7.md)
- 2023-06-30 to 2023-09-30 | quarterly_operating_income | 117,000,000 United States dollar | superseded | [clm_73EDDFD6C69B](/claim/clm_73EDDFD6C69B.md)
- 2023-06-30 to 2023-09-30 | shares_outstanding | 204,300,000 shares | superseded | [clm_96816E62DE01](/claim/clm_96816E62DE01.md)
- 2023-06-30 to 2023-09-30 | cash_and_equivalents | 1,663,000,000 United States dollar | superseded | [clm_B6B05E256452](/claim/clm_B6B05E256452.md)
- 2023-09-30 to 2024-03-31 | quarterly_research_and_development | 549,000,000 United States dollar | superseded | [clm_02BA958608AC](/claim/clm_02BA958608AC.md)
- 2023-09-30 to 2024-03-31 | quarterly_operating_income | 231,000,000 United States dollar | superseded | [clm_0F0FB463644D](/claim/clm_0F0FB463644D.md)
- 2023-09-30 to 2024-03-31 | quarterly_revenue | 2,288,000,000 United States dollar | superseded | [clm_220D33E5467D](/claim/clm_220D33E5467D.md)
- 2023-09-30 to 2024-03-31 | quarterly_net_income | 242,000,000 United States dollar | superseded | [clm_59A6EB1B95AF](/claim/clm_59A6EB1B95AF.md)
- 2023-09-30 to 2023-12-31 | total_equity | 7,182,000,000 United States dollar | superseded | [clm_5F0316C6831E](/claim/clm_5F0316C6831E.md)
- 2023-09-30 to 2023-12-31 | total_assets | 15,091,000,000 United States dollar | superseded | [clm_9EF57AD7C7CF](/claim/clm_9EF57AD7C7CF.md)
- 2023-09-30 to 2024-01-19 | shares_outstanding | 205,000,000 shares | superseded | [clm_C1E45AE0F00E](/claim/clm_C1E45AE0F00E.md)
- 2023-09-30 to 2023-12-31 | cash_and_equivalents | 1,112,000,000 United States dollar | superseded | [clm_F2A114FD4BCD](/claim/clm_F2A114FD4BCD.md)
- 2023-12-31 to 2024-03-31 | cash_and_equivalents | 1,897,000,000 United States dollar | superseded | [clm_02436AABD54D](/claim/clm_02436AABD54D.md)
- 2023-12-31 to 2024-12-31 | revenue | 8,971,000,000 United States dollar | superseded | [clm_2ECD5F083DEB](/claim/clm_2ECD5F083DEB.md)
- 2023-12-31 to 2024-12-31 | operating_income | 762,000,000 United States dollar | superseded | [clm_385B5782A0D2](/claim/clm_385B5782A0D2.md)
- 2023-12-31 to 2024-12-31 | net_income | 1,731,000,000 United States dollar | superseded | [clm_647CB5BFD6B8](/claim/clm_647CB5BFD6B8.md)
- 2023-12-31 to 2024-03-31 | total_equity | 7,628,000,000 United States dollar | superseded | [clm_7AA6F54EC2A5](/claim/clm_7AA6F54EC2A5.md)
- 2023-12-31 to 2024-12-31 | research_and_development | 2,124,000,000 United States dollar | superseded | [clm_847F2D483BD7](/claim/clm_847F2D483BD7.md)
- 2023-12-31 to 2024-03-31 | total_assets | 17,387,000,000 United States dollar | superseded | [clm_D7E1331166F9](/claim/clm_D7E1331166F9.md)

## 2024

- 2024-01-19 to 2024-04-30 | shares_outstanding | 205,000,000 shares | superseded | [clm_130E0A615BE7](/claim/clm_130E0A615BE7.md)
- 2024-03-31 to 2024-06-30 | total_equity | 8,107,000,000 United States dollar | superseded | [clm_18C75A853C80](/claim/clm_18C75A853C80.md)
- 2024-03-31 to 2024-06-30 | cash_and_equivalents | 2,056,000,000 United States dollar | superseded | [clm_4374EC896953](/claim/clm_4374EC896953.md)
- 2024-03-31 to 2024-06-30 | quarterly_net_income | 347,000,000 United States dollar | superseded | [clm_79AEB1DAA55B](/claim/clm_79AEB1DAA55B.md)
- 2024-03-31 to 2024-06-30 | quarterly_research_and_development | 606,000,000 United States dollar | superseded | [clm_89B99609F1B7](/claim/clm_89B99609F1B7.md)
- 2024-03-31 to 2024-06-30 | total_assets | 17,544,000,000 United States dollar | superseded | [clm_9D4CE1D89914](/claim/clm_9D4CE1D89914.md)
- 2024-03-31 to 2024-06-30 | quarterly_operating_income | 332,000,000 United States dollar | superseded | [clm_CCB6C00759FF](/claim/clm_CCB6C00759FF.md)
- 2024-03-31 to 2024-06-30 | quarterly_revenue | 2,603,000,000 United States dollar | superseded | [clm_CF9AF58CFC48](/claim/clm_CF9AF58CFC48.md)
- 2024-04-30 to 2024-06-30 | shares_outstanding | 205,000,000 shares | superseded | [clm_0FD25F09C72A](/claim/clm_0FD25F09C72A.md)
- 2024-06-30 to 2024-09-30 | quarterly_operating_income | 240,000,000 United States dollar | superseded | [clm_06D77419C62A](/claim/clm_06D77419C62A.md)
- 2024-06-30 to 2024-09-30 | quarterly_revenue | 2,627,000,000 United States dollar | superseded | [clm_0761A7A5AB67](/claim/clm_0761A7A5AB67.md)
- 2024-06-30 to 2024-09-30 | quarterly_research_and_development | 643,000,000 United States dollar | superseded | [clm_0D592B03ECAD](/claim/clm_0D592B03ECAD.md)
- 2024-06-30 to 2024-09-30 | cash_and_equivalents | 2,159,000,000 United States dollar | superseded | [clm_4BD11938AE5D](/claim/clm_4BD11938AE5D.md)
- 2024-06-30 to 2024-09-30 | shares_outstanding | 206,000,000 shares | superseded | [clm_890D864F2FC9](/claim/clm_890D864F2FC9.md)
- 2024-06-30 to 2024-09-30 | total_assets | 18,207,000,000 United States dollar | superseded | [clm_96706AC572D3](/claim/clm_96706AC572D3.md)
- 2024-06-30 to 2024-09-30 | quarterly_net_income | 262,000,000 United States dollar | superseded | [clm_A05093FB9BFF](/claim/clm_A05093FB9BFF.md)
- 2024-06-30 to 2024-09-30 | total_equity | 8,666,000,000 United States dollar | superseded | [clm_B58F3DE02CF8](/claim/clm_B58F3DE02CF8.md)
- 2024-09-30 to 2025-03-31 | quarterly_research_and_development | 626,000,000 United States dollar | superseded | [clm_033AAB666EDA](/claim/clm_033AAB666EDA.md)
- 2024-09-30 to 2024-12-31 | total_equity | 9,290,000,000 United States dollar | superseded | [clm_1F2CE28A5DAB](/claim/clm_1F2CE28A5DAB.md)
- 2024-09-30 to 2025-03-31 | quarterly_net_income | 432,000,000 United States dollar | superseded | [clm_5965944E7528](/claim/clm_5965944E7528.md)
- 2024-09-30 to 2024-12-31 | cash_and_equivalents | 1,885,000,000 United States dollar | superseded | [clm_5A7FF290DDA8](/claim/clm_5A7FF290DDA8.md)
- 2024-09-30 to 2025-03-31 | quarterly_operating_income | 418,000,000 United States dollar | superseded | [clm_6C5F6BF325A0](/claim/clm_6C5F6BF325A0.md)
- 2024-09-30 to 2025-03-31 | quarterly_revenue | 2,797,000,000 United States dollar | superseded | [clm_A7350C7664E3](/claim/clm_A7350C7664E3.md)
- 2024-09-30 to 2025-01-23 | shares_outstanding | 206,000,000 shares | superseded | [clm_BD236A2AD3C6](/claim/clm_BD236A2AD3C6.md)
- 2024-09-30 to 2024-12-31 | total_assets | 18,434,000,000 United States dollar | superseded | [clm_EBA7232E839C](/claim/clm_EBA7232E839C.md)
- 2024-10-28 | coo | Amit Zavery | valid | [clm_86C86C078626](/claim/clm_86C86C078626.md)
- 2024-10-28 | president | Amit Zavery | valid | [clm_AFAA2EFF8B5F](/claim/clm_AFAA2EFF8B5F.md)
- 2024-12-31 to 2025-12-31 | revenue | 10,984,000,000 United States dollar | superseded | [clm_2C0FB9E6C22C](/claim/clm_2C0FB9E6C22C.md)
- 2024-12-31 to 2025-03-31 | total_assets | 20,383,000,000 United States dollar | superseded | [clm_687983CC887B](/claim/clm_687983CC887B.md)
- 2024-12-31 to 2025-12-31 | research_and_development | 2,543,000,000 United States dollar | superseded | [clm_96AB17499557](/claim/clm_96AB17499557.md)
- 2024-12-31 to 2025-03-31 | total_equity | 9,609,000,000 United States dollar | superseded | [clm_A3DBB37A4A55](/claim/clm_A3DBB37A4A55.md)
- 2024-12-31 to 2025-12-31 | operating_income | 1,364,000,000 United States dollar | superseded | [clm_E6B299577041](/claim/clm_E6B299577041.md)
- 2024-12-31 to 2025-12-31 | net_income | 1,425,000,000 United States dollar | superseded | [clm_ECA2630A7046](/claim/clm_ECA2630A7046.md)
- 2024-12-31 to 2025-03-31 | cash_and_equivalents | 2,304,000,000 United States dollar | superseded | [clm_FDBEDFB2355B](/claim/clm_FDBEDFB2355B.md)

## 2025

- 2025-01-23 to 2025-03-31 | shares_outstanding | 206,000,000 shares | superseded | [clm_9B97F6BB9B3D](/claim/clm_9B97F6BB9B3D.md)
- 2025-03-31 to 2025-06-30 | quarterly_operating_income | 451,000,000 United States dollar | superseded | [clm_04D9F4284534](/claim/clm_04D9F4284534.md)
- 2025-03-31 to 2025-06-30 | quarterly_net_income | 460,000,000 United States dollar | superseded | [clm_1C83FD5934AA](/claim/clm_1C83FD5934AA.md)
- 2025-03-31 to 2025-06-30 | quarterly_research_and_development | 703,000,000 United States dollar | superseded | [clm_25ABF3AC4658](/claim/clm_25ABF3AC4658.md)
- 2025-03-31 to 2025-06-30 | total_equity | 10,139,000,000 United States dollar | superseded | [clm_6D42DE13A48E](/claim/clm_6D42DE13A48E.md)
- 2025-03-31 to 2025-06-30 | shares_outstanding | 207,000,000 shares | superseded | [clm_6E33C213FA2E](/claim/clm_6E33C213FA2E.md)
- 2025-03-31 to 2025-06-30 | cash_and_equivalents | 3,369,000,000 United States dollar | superseded | [clm_AFEFF39E2FB4](/claim/clm_AFEFF39E2FB4.md)
- 2025-03-31 to 2025-06-30 | total_assets | 20,972,000,000 United States dollar | superseded | [clm_CBE227169806](/claim/clm_CBE227169806.md)
- 2025-03-31 to 2025-06-30 | quarterly_revenue | 3,088,000,000 United States dollar | superseded | [clm_D5C4AF0FAC9A](/claim/clm_D5C4AF0FAC9A.md)
- 2025-06-30 to 2025-09-30 | total_equity | 10,932,000,000 United States dollar | superseded | [clm_0BC256A05E84](/claim/clm_0BC256A05E84.md)
- 2025-06-30 to 2025-09-30 | quarterly_research_and_development | 734,000,000 United States dollar | superseded | [clm_5227A941BFE5](/claim/clm_5227A941BFE5.md)
- 2025-06-30 to 2025-09-30 | total_assets | 22,051,000,000 United States dollar | superseded | [clm_530C71AA61A5](/claim/clm_530C71AA61A5.md)
- 2025-06-30 to 2025-09-30 | shares_outstanding | 208,000,000 shares | superseded | [clm_7A2BA796716B](/claim/clm_7A2BA796716B.md)
- 2025-06-30 to 2025-09-30 | quarterly_revenue | 3,215,000,000 United States dollar | superseded | [clm_90AAE521EA37](/claim/clm_90AAE521EA37.md)
- 2025-06-30 to 2025-09-30 | quarterly_net_income | 385,000,000 United States dollar | superseded | [clm_DB7C1F28E514](/claim/clm_DB7C1F28E514.md)
- 2025-06-30 to 2025-09-30 | cash_and_equivalents | 3,124,000,000 United States dollar | superseded | [clm_E9F2DA6FDAFB](/claim/clm_E9F2DA6FDAFB.md)
- 2025-06-30 to 2025-09-30 | quarterly_operating_income | 358,000,000 United States dollar | superseded | [clm_EB2E403C93B7](/claim/clm_EB2E403C93B7.md)
- 2025-09-30 to 2025-12-31 | cash_and_equivalents | 2,725,000,000 United States dollar | superseded | [clm_27ED80A8E673](/claim/clm_27ED80A8E673.md)
- 2025-09-30 to 2026-03-31 | quarterly_net_income | 502,000,000 United States dollar | superseded | [clm_2D2CA5DB7F29](/claim/clm_2D2CA5DB7F29.md)
- 2025-09-30 to 2026-03-31 | quarterly_research_and_development | 750,000,000 United States dollar | superseded | [clm_90E803C7D64E](/claim/clm_90E803C7D64E.md)
- 2025-09-30 to 2025-12-31 | total_equity | 11,301,000,000 United States dollar | superseded | [clm_A02D70B39A8A](/claim/clm_A02D70B39A8A.md)
- 2025-09-30 to 2026-03-31 | quarterly_revenue | 3,407,000,000 United States dollar | superseded | [clm_B29141B2B0C7](/claim/clm_B29141B2B0C7.md)
- 2025-09-30 to 2025-12-31 | total_assets | 21,789,000,000 United States dollar | superseded | [clm_BC8A9F4375F7](/claim/clm_BC8A9F4375F7.md)
- 2025-09-30 to 2026-01-23 | shares_outstanding | 208,000,000 shares | superseded | [clm_D80FB7D6A1A3](/claim/clm_D80FB7D6A1A3.md)
- 2025-09-30 to 2026-03-31 | quarterly_operating_income | 572,000,000 United States dollar | superseded | [clm_F2050D207FD7](/claim/clm_F2050D207FD7.md)
- 2025-12-31 | net_income | 1,748,000,000 United States dollar | valid | [clm_171D93571AAD](/claim/clm_171D93571AAD.md)
- 2025-12-31 | employees | 29,187 | valid | [clm_245E64133C61](/claim/clm_245E64133C61.md)
- 2025-12-31 to 2026-03-31 | total_assets | 26,038,000,000 United States dollar | superseded | [clm_87C6811823B3](/claim/clm_87C6811823B3.md)
- 2025-12-31 | research_and_development | 2,960,000,000 United States dollar | valid | [clm_A3CECEB0FFA0](/claim/clm_A3CECEB0FFA0.md)
- 2025-12-31 to 2026-03-31 | total_equity | 12,964,000,000 United States dollar | superseded | [clm_BC6BDEB66268](/claim/clm_BC6BDEB66268.md)
- 2025-12-31 to 2026-03-31 | cash_and_equivalents | 3,726,000,000 United States dollar | superseded | [clm_BD76D73492F1](/claim/clm_BD76D73492F1.md)
- 2025-12-31 | revenue | 13,278,000,000 United States dollar | valid | [clm_E7BD5A18ADBC](/claim/clm_E7BD5A18ADBC.md)
- 2025-12-31 | operating_income | 1,824,000,000 United States dollar | valid | [clm_FC7A40B2D75E](/claim/clm_FC7A40B2D75E.md)

## 2026

- 2026-01-23 to 2026-03-31 | shares_outstanding | 1,046,000,000 shares | superseded | [clm_7DDEC7334521](/claim/clm_7DDEC7334521.md)
- 2026-03-31 to 2026-06-30 | total_assets | 24,381,000,000 United States dollar | superseded | [clm_30B408E967CF](/claim/clm_30B408E967CF.md)
- 2026-03-31 to 2026-06-30 | quarterly_net_income | 469,000,000 United States dollar | superseded | [clm_4DB34C5FFDD2](/claim/clm_4DB34C5FFDD2.md)
- 2026-03-31 to 2026-06-30 | total_equity | 11,728,000,000 United States dollar | superseded | [clm_7B97FFDF8417](/claim/clm_7B97FFDF8417.md)
- 2026-03-31 to 2026-06-30 | cash_and_equivalents | 2,702,000,000 United States dollar | superseded | [clm_7CF17750EBBA](/claim/clm_7CF17750EBBA.md)
- 2026-03-31 to 2026-06-30 | quarterly_research_and_development | 823,000,000 United States dollar | superseded | [clm_9E802BBB1145](/claim/clm_9E802BBB1145.md)
- 2026-03-31 to 2026-06-30 | quarterly_operating_income | 503,000,000 United States dollar | superseded | [clm_EE01FA26E325](/claim/clm_EE01FA26E325.md)
- 2026-03-31 to 2026-06-30 | quarterly_revenue | 3,770,000,000 United States dollar | superseded | [clm_EF98AACF9587](/claim/clm_EF98AACF9587.md)
- 2026-03-31 to 2026-06-30 | shares_outstanding | 1,031,000,000 shares | superseded | [clm_FE1DAADC7DED](/claim/clm_FE1DAADC7DED.md)
- 2026-06-30 | quarterly_operating_income | 162,000,000 United States dollar | valid | [clm_4483BE1968D5](/claim/clm_4483BE1968D5.md)
- 2026-06-30 | quarterly_net_income | 298,000,000 United States dollar | valid | [clm_4EF3D0F69E83](/claim/clm_4EF3D0F69E83.md)
- 2026-06-30 | total_equity | 12,516,000,000 United States dollar | valid | [clm_585D77C428D0](/claim/clm_585D77C428D0.md)
- 2026-06-30 | shares_outstanding | 1,034,000,000 shares | valid | [clm_91178FEFC85A](/claim/clm_91178FEFC85A.md)
- 2026-06-30 | quarterly_research_and_development | 915,000,000 United States dollar | valid | [clm_94D3341C1857](/claim/clm_94D3341C1857.md)
- 2026-06-30 | cash_and_equivalents | 2,503,000,000 United States dollar | valid | [clm_AD31517E88FB](/claim/clm_AD31517E88FB.md)
- 2026-06-30 | total_assets | 31,666,000,000 United States dollar | valid | [clm_C1AE077FDB75](/claim/clm_C1AE077FDB75.md)
- 2026-06-30 | quarterly_revenue | 3,987,000,000 United States dollar | valid | [clm_EEFD30EAF91E](/claim/clm_EEFD30EAF91E.md)
---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.